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Addendum

VALORIZATION
Social relevance
The number of people with overweight is increasing rapidly worldwide, reaching pandemic proportions. In 2014, 39% of the adults were overweight and 13% were obese worldwide. A combination of excessive food intake (high-caloric, high-fat) and low physical activity are the primary contributors to the development of overweight (1) .
Overweight is associated with the development of chronic metabolic disease such as type 2 diabetes mellitus (T2DM). An important characteristic of T2DM is that the metabolic effects of insulin on glucose metabolism are blunted (2) . In the healthy state, the plasma concentration of glucose is tightly regulated within a narrow range. After food intake, the plasma concentration of the hormone insulin raises, causing the uptake of glucose into tissue, thereby regulating plasma glucose levels. In T2DM, this regulation is poor and hyperglycemia can develop. As the prevalence of T2DM is tightly linked to obesity, also T2DM, just like overweight, is increasing dramatically worldwide. Recent estimates reported 171 million people worldwide diagnosed with T2DM in the year 2000 and expected to increase towards 366 million in 2030 (5) . Since T2DM is associated with reduced quality of life, decreased life expectancy, and increased risk of morbidities such as cardiovascular diseases, the diabetes-related costs are a major burden on our health care systems. Therefore, it is important to increase our understanding of this disease to improve prevention and cure. Nowadays treatment of T2DM consist of glucose lowering medication, diet, increasing physical activity or a combination of these. However, T2DM is a complex metabolic disease whereby underlying mechanism are yet not completely understood and not all patients respond well to the conventional treatment.
Understanding the underlying mechanisms might result in new treatment strategies.
Activities and products
The research performed in this thesis was executed as a tight collaboration of the In the current thesis we applied non-invasive magnetic resonance spectroscopy (MRS) techniques to investigate acetylcarnitine metabolism in healthy and metabolically compromised individuals. The results presented in the current thesis are or will be implemented in original scientific articles. These articles have been published or are submitted to international well-recognized peer-reviewed journals. The articles can be found online and can be assessed by scientist worldwide. In addition, results and knowledge obtained form the studies performed in this thesis have been presented and communicated to the scientific community on national and international conferences via oral presentations and posters.
In this way, the international scientific community can take notice of the current results, thereby advancing the knowledge of the field.
Innovation
Our knowledge about the role of carnitine metabolism and specifically, acetylcarnitine formation in metabolic flexibility and insulin sensitivity in humans is currently limited.
One of the reasons is that, until recently, the only means to quantify acetylcarnitine was the determination by mass spectrometry in muscle biopsies (7 
Target groups
In this thesis we reported that supplementation with carnitine positively affects the formation of acetylcarnitine and improved metabolic flexibility in individuals at risk to develop type 2 diabetes. Therefore, carnitine supplementation might be an interesting aid to postpone or even prevent the development of T2DM in these individuals at risk.
This strikes out the great importance of carnitine in this pre-diabetic population. Since carnitine is a free available food supplement, carnitine intake is a feasible and directly applicable strategy to postpone the development of diabetes. The latter could be of importance to pharmaceutical industry to improve the use of the food supplement carnitine.
Although further research is needed to investigate the effect of carnitine in T2 diabetic 
